Literature DB >> 18797437

Therapy insight: Management of cardiovascular disease in patients with cancer and cardiac complications of cancer therapy.

Aarif Y Khakoo1, Edward T H Yeh.   

Abstract

Cardiac disease in patients with cancer or caused by cancer therapy is a clinical problem of emerging importance. Optimum management of cardiovascular disease can mean that patients with cancer can successfully receive therapies to treat their malignancy and can reduce morbidity and mortality due to cardiovascular disease in cancer survivors. The presence of cancer and cancer-related morbidities substantially complicates the management of cardiovascular disease in cancer patients. In this Review, we discuss management strategies for cardiovascular disease in patients with cancer, focusing on the prevention and treatment of congestive heart failure and myocardial infarction.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18797437     DOI： 10.1038/ncponc1225

Source DB:  PubMed          Journal:  Nat Clin Pract Oncol        ISSN： 1743-4254


  25 in total

1.  Frequency and management of troponin I elevation in patients treated with molecular targeted therapies in phase I trials.

Authors:  Stephane Ederhy; Christophe Massard; Ghislaine Dufaitre; Ratio Balheda; Catherine Meuleman; Carlos Gomez Rocca; Hassane Izzedine; Ariel Cohen; Jean-Charles Soria
Journal:  Invest New Drugs       Date:  2010-10-06       Impact factor: 3.850

2.  A case of variant angina in a patient under chronic treatment with sorafenib.

Authors:  Italo Porto; Andrea Leo; Luca Miele; Maurizio Pompili; Raffaele Landolfi; Filippo Crea
Journal:  Nat Rev Clin Oncol       Date:  2010-05-18       Impact factor: 66.675

Review 3.  Cancer as a Risk Factor for Cardiovascular Disease.

Authors:  Dana Elena Giza; Gloria Iliescu; Saamir Hassan; Konstantinos Marmagkiolis; Cezar Iliescu
Journal:  Curr Oncol Rep       Date:  2017-06       Impact factor: 5.075

4.  The Yale Fitness Intervention Trial in female cancer survivors: Cardiovascular and physiological outcomes.

Authors:  M Tish Knobf; Sangchoon Jeon; Barbara Smith; Lyndsay Harris; Siobhan Thompson; Mitchel R Stacy; Karl Insogna; Albert J Sinusas
Journal:  Heart Lung       Date:  2017-08-10       Impact factor: 2.210

Review 5.  Acute Coronary Syndrome Management in Cancer Patients.

Authors:  Malek Al-Hawwas; Despina Tsitlakidou; Neha Gupta; Cezar Iliescu; Mehmet Cilingiroglu; Konstantinos Marmagkiolis
Journal:  Curr Oncol Rep       Date:  2018-08-22       Impact factor: 5.075

6.  First do no harm: population-based study shows non-evidence-based trastuzumab prescription may harm elderly women with breast cancer.

Authors:  Ya-Chen Tina Shih; Ying Xu; Wenli Dong; Fabrice Smieliauskas; Sharon Giordano; Yu Shen
Journal:  Breast Cancer Res Treat       Date:  2014-02-21       Impact factor: 4.872

7.  Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrations.

Authors:  Ramon Kaneno; Galina V Shurin; Irina L Tourkova; Michael R Shurin
Journal:  J Transl Med       Date:  2009-07-10       Impact factor: 5.531

Review 8.  The Role of Imaging with Cardiac Computed Tomography in Cardio-Oncology Patients.

Authors:  Barbora Pitekova; Sriram Ravi; Shimoli V Shah; Beata Mladosievicova; Stephen Heitner; Maros Ferencik
Journal:  Curr Cardiol Rep       Date:  2016-09       Impact factor: 2.931

Review 9.  Unintended Effects of GPCR-Targeted Drugs on the Cancer Phenotype.

Authors:  Abigail C Cornwell; Michael E Feigin
Journal:  Trends Pharmacol Sci       Date:  2020-10-22       Impact factor: 14.819

Review 10.  Cardiomyocyte autophagy and cancer chemotherapy.

Authors:  Dan L Li; Joseph A Hill
Journal:  J Mol Cell Cardiol       Date:  2013-11-14       Impact factor: 5.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.